Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Dr Reddys Laboratories News Editors

News Widget

Display the Dr Reddys Laboratories news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Dr Reddys Laboratories News

News on Dr Reddys Laboratories (Ticker: RDY) continually updated from thousands of sources around the net.

3 hrs ago | Drugs.com

Teva Pulls Plans to Market Generic Lipitor

May 29--Teva Pharmaceutical Industries Ltd. has decided not to market Atorvastatin, the generic version of Pfizer Inc.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Lipitor, Atorvastatin (generic), Medication, Pfizer, Healthcare Industry, Cholesterol, Health, Food and Drug Administration

Fri May 25, 2012

GuruFocus.com

Dr. Reddy's Laboratories: Should Continue to Gain Market Share in Lucrative Markets

Dr. Reddy's Laboratories , India's second-largest pharmaceutical company, recently reported a fourth-quarter and full-year 2012 performance that beat expectations on revenues but missed estimates on earnings.

Comment?

Related Topix: Biotech

Thu May 24, 2012

PR-inside.com

Recently released market study: Dr. Reddy's Laboratories Limited - SWOT Analysis

Dr. Reddy's Laboratories Limited - SWOT Analysis company profile is the essential source for top-level company data and information.

Comment?

Related Topix: Biotech, India, World News

Tue May 22, 2012

PR-inside.com

Recently released market study: Dr. Reddy's Laboratories Limited - Strategy and SWOT Report

Reddy's Laboratories Limited - Strategy and SWOT Report, is a source of comprehensive company data and information.

Comment?

Related Topix: Biotech, India, World News

CisionWire

Newly Approved Blood Thinner Competition to Pradaxa?

Pharmaceutical companies continue to take advantage of the uncertainty surrounding the safety of Pradaxa , as nine companies have gained approval to create the generic version of the blood thinning drug Plavix .

Comment?

Related Topix: Healthcare Law, Law, Medicine, Plavix, Clopidogrel (generic), Medication, Biotech

Freshnews

Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories

NEW YORK, May 22, 2012 /PRNewswire/ -- Genpact Limited , a global leader in business process and technology management, today announced that it has signed an agreement with Dr.

Comment?

Related Topix: Globecomm Systems, Cable & Satellite, Telecom, Headstrong, Computers, IT Services, Biotech, World News, India,

Mon May 21, 2012

Zacks

Generic Launches Continue at Mylan

Analyst Report ), recently announced that it has received final approval from the U.S. Food & Drug Administration to launch generic versions of Plavix , 75 mg and 300 mg.

Comment?

Related Topix: Food and Drug Administration, Medicine, Plavix, Clopidogrel (generic), Medication, Stroke, Heart Attack, Health, Biotech

PR-inside.com

Dr. Reddy's Laboratories Limited - SWOT Analysis - new company profile report published

Reddy's Laboratories Limited - SWOT Analysis - a new company profile report on companiesandmarkets.com Dr.

Comment?

Related Topix: Biotech, India, World News

Sun May 20, 2012

Freshnews

Dr. Reddy's Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules

HYDERABAD, India -- -- Dr. Reddy's Laboratories announced today that it has launched over-the-counter Lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr.

Comment?

Related Topix: Medicine, Prevacid, Lansoprazole (generic), Medication, World News, India, Biotech

Fri May 18, 2012

PR-inside.com

Dr. Reddy's Laboratories Limited - SWOT Analysis - new company profile report published

Reddy's Laboratories Limited - SWOT Analysis - a new company profile report on companiesandmarkets.com Dr.

Comment?

Related Topix: Biotech, India, World News

Thu May 17, 2012

Customer Interaction Solutions

Dr. Reddy's Announces the Launch of Clopidogrel Tablets, USP

Dr. Reddy's Laboratories announced today that it has launched CLOPIDOGREL TABLETS, USP 75 mg & 300 mg , a bioequivalent generic version of PLAVIX, in the U.S. market on May 18, 2012.

Comment?

Related Topix: Medicine, Plavix, Clopidogrel (generic), Medication, Biotech, Marketing

Tue May 15, 2012

StockMarketsReview.com

Dr. Reddy's Laboratories 4QFY2012 performance highlights and results update

Dr. Reddy's Laboratories reported higher-than-expected 4QFY2012 top-line performance, while its bottom line came in below expectations.

Comment?

Related Topix: Biotech

Fri May 11, 2012

Drugs.com

Dr. Reddy's Revenues Cross $2 Billion Milestone* in FY12

HYDERABAD, India-- --May 11, 2012 - Dr. Reddy's Laboratories Ltd. today announced its audited consolidated financial results for the quarter and full year ended March 31, 2012 under International Financial Reporting Standards .

Comment?

Related Topix: India, World News, Biotech

Fox News

Dr Reddy's Jan-March Net Grows 2.7%; Misses View On One-Time Charge

Dr. Reddy's Laboratories Ltd. Friday disappointed investors with a slim 2.7% rise in its fourth-quarter net profit, but this was due mainly to a one-time charge.

Comment?

Related Topix: Biotech, Medicine, Schizophrenia, Health, Business News

Express India

Dr Reddy's Laboratories Q4 net up 2%

Jobs Commodities Automobiles Insurance Real Estate Travel & Tourism Health & Pharma Lifestyle Media Power Telecom Infotech Retail Infrastructure Editor's Picks New Delhi: Drug firm Dr Reddy's Laboratories today reported 2.46 per cent increase in consolidated net profit to Rs 342.70 crore for the fourth quarter ended March 31, 2012, over the same ... (more)

Comment?

Related Topix: Biotech

Thu May 03, 2012

Reuters

India's Dr Reddy's gets U.S. nod for osteoporosis drug

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.

Comment?

Related Topix: Osteoporosis, Medicine, Biotech, Viramune, Nevirapine (generic), Medication

Los Angeles Jobs

Also on Topix